The potential of high temporal resolution automatic measurements of PM composition as an alternative to the filter-based manual method used in routine monitoring.

Under the EU Air Quality Directive (AQD) 2008/50/EC member states are required to undertake routine monitoring of PM composition at background stations. The AQD states for PM speciation this should include at least: nitrate , sulfate , chloride (Cl), ammonium (NH4), sodium (Na), potassium (K), magnesium (Mg), calcium (Ca), elemental carbon (EC) and organic carbon (OC). Until 2017, it was the responsibility of each country to determine the methodology used to report the composition for the inorganic components of PM.

Meta-analyses of phase I dose-finding studies: Application for the development of protein kinase inhibitors in oncology.

This study aimed to assess the feasibility of applying two recent phase I meta-analyses methods to protein kinase inhibitors (PKIs) developed in oncology and to identify situations where these methods could be both feasible and useful. This ancillary study used data from a systematic review conducted to identify dose-finding studies for PKIs. PKIs selected for meta-analyses were required to have at least five completed dose-finding studies involving cancer patients, with available results, and dose escalation guided by toxicity assessment.

Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology.

Over the past decade, the emergence of patient-derived tumor organoids (PDTOs) has broadened the repertoire of preclinical models and progressively revolutionized three-dimensional cell culture in oncology. PDTO can be grown from patient tumor samples with high efficiency and faithfully recapitulates the histological and molecular characteristics of the original tumor. Therefore, PDTOs can serve as invaluable tools in oncology research, and their translation to clinical practice is exciting for the future of precision medicine in oncology.